| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/2011 | US8022061 5-(Methoxymethyl)-1-(5-methyl-4-(thiophen-2-yl)pyrimidin-2-yl)-N-(pyridin-4-ylmethyl)-1H-pyrazole-4-carboxamide; for the treatment or prevention of type 2 diabetes and type 2 diabetes-related conditions |
| 09/20/2011 | US8022060 Spirocyclic heterocyclic derivatives and methods of their use |
| 09/20/2011 | US8022059 Indazole acrylic acid amide compound |
| 09/20/2011 | US8022058 Agents for preventing and treating disorders involving modulation of the RyR receptors |
| 09/20/2011 | US8022057 MAPK/ERK kinase inhibitors |
| 09/20/2011 | US8022056 Compositions and methods for the treatment of cancer |
| 09/20/2011 | US8022055 Betulinic acid derivatives |
| 09/20/2011 | US8022054 Liquid ganaxolone formulations and methods for the making and use thereof |
| 09/20/2011 | US8022053 Oral solid dosage forms containing a low dose of estradiol |
| 09/20/2011 | US8022052 Inhibition of PPAR gamma expression by specific osteogenic oxysterols |
| 09/20/2011 | US8022051 Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine |
| 09/20/2011 | US8022050 Compound for inhibiting TRPA1 function and use thereof |
| 09/20/2011 | US8022049 Polysaccharide produced by microorganism belonging to genus Bifidobacterium |
| 09/20/2011 | US8022048 Method of treating vitamin B12 deficiency |
| 09/20/2011 | US8022047 Combination anticancer agents |
| 09/20/2011 | US8022044 Compositions and methods for therapeutic use |
| 09/20/2011 | US8022043 alpha -galactosylceramide; glycolipids; modulate NK T cells; autoimmune disease, cancer, type 1 diabetes |
| 09/20/2011 | US8022042 Composition and methods for the treatment of cancer |
| 09/20/2011 | US8022032 Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
| 09/20/2011 | US8021861 Pathogenic Escherichia coli associated protein |
| 09/20/2011 | US8021832 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 09/20/2011 | US8021831 Determination of cancer cells; analyzing gene expression; cell cycle profile |
| 09/20/2011 | US8021700 Topical skin salve and associated use therefor |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021688 Solid dispersion is formed from at least one active component and a carrier characterized in that the carrier is a mixture of polyvinylpyrrolidone (PVP), a polyethylene glycol (PEG) which is semi-solid or solid at temperatures of 17 to 22 |
| 09/20/2011 | US8021687 Modified release compositions of milnacipran |
| 09/20/2011 | US8021686 Serum and/or intercellular degradation and clearance prevention; delivering antisense nucleic acids and/or ribozymes; high drug to lipid ratios |
| 09/20/2011 | US8021684 Haemostatic composition comprising hyaluronic acid |
| 09/20/2011 | US8021681 Obesity; antidiabetic agents ; insulin resistance; hypotensive agents; increase dopaminergic agents; controlling concentration of protein, fats, carbohydrates and calories |
| 09/20/2011 | US8021680 Controlled release bioactive agent delivery device |
| 09/20/2011 | US8021665 Identification and application of antibiotic synergy |
| 09/20/2011 | US8021652 Biodegradable branched polylactide derivatives capable of forming polymeric micelles, and their preparation method and use |
| 09/20/2011 | US8021350 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 09/20/2011 | CA2669311C Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 09/20/2011 | CA2657106C Aminoindane derivative or salt thereof |
| 09/20/2011 | CA2617957C Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 09/20/2011 | CA2599219C Compositions and methods for treating and preventing cardiomyopathy and heart disease |
| 09/20/2011 | CA2597069C Pyridazine derivatives and their use as therapeutic agents |
| 09/20/2011 | CA2589146C Process for producing muscarine receptor antagonist and intermediate therefor |
| 09/20/2011 | CA2583737C Compounds and compositions as protein kinase inhibitors |
| 09/20/2011 | CA2573346C Hepatitis c inhibitor peptide analogs |
| 09/20/2011 | CA2573204C Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids |
| 09/20/2011 | CA2560523C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 09/20/2011 | CA2548668C Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/20/2011 | CA2541458C Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 09/20/2011 | CA2536632C Therapy-enhancing glucan |
| 09/20/2011 | CA2525470C External patch containing estrogen and/or progestogen |
| 09/20/2011 | CA2516934C Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 09/20/2011 | CA2516233C 2-propylidene-19-nor-vitamin d compounds |
| 09/20/2011 | CA2511735C A method for treating renal failure using levosimendan or its metabolite or salts thereof |
| 09/20/2011 | CA2510760C Stimulation of in vivo production of proteins with formulation comprising leucine |
| 09/20/2011 | CA2510534C Compositions useful as inhibitors of protein kinases |
| 09/20/2011 | CA2509225C Indol derivatives and their use as 5-ht ligands |
| 09/20/2011 | CA2508923C Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 09/20/2011 | CA2507561C A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 09/20/2011 | CA2506532C Anhydrous crystalline azido cytosine hemisulfate derivative |
| 09/20/2011 | CA2505368C Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same |
| 09/20/2011 | CA2505033C Non-nucleoside reverse transcriptase inhibitors |
| 09/20/2011 | CA2503868C Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors |
| 09/20/2011 | CA2493483C Endiandric acid h as c-maf inhibitors derivatives for use against asthma |
| 09/20/2011 | CA2492874C Taste masked oral composition of telithromycin |
| 09/20/2011 | CA2488723C Use of pullulan as a slowly digested carbohydrate |
| 09/20/2011 | CA2482637C New esters of hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| 09/20/2011 | CA2478253C Composition for hard tissue augmentation |
| 09/20/2011 | CA2476859C Water-based delivery systems |
| 09/20/2011 | CA2476619C Pet food composition for skin photoprotection |
| 09/20/2011 | CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/20/2011 | CA2473209C Stimulation of the immune system with polydextrose |
| 09/20/2011 | CA2473200C Extended release compositions comprising as active compound venlafaxine hydrochloride |
| 09/20/2011 | CA2471943C .beta.-amyloid protein production-secretion inhibitors |
| 09/20/2011 | CA2471578C Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments |
| 09/20/2011 | CA2470102C Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 09/20/2011 | CA2468552C 3-.beta.-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof |
| 09/20/2011 | CA2467774C Solubilized topoisomerase poisons |
| 09/20/2011 | CA2467237C Method of preventing or treating benign gynaecological disorders |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2462251C Animal feeds including actives and methods of using same |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2458210C Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar-activators |
| 09/20/2011 | CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 09/20/2011 | CA2455328C New use of cyclolignans and new cyclolignans |
| 09/20/2011 | CA2453817C Organophosphorus compounds for the activation of gamma/delta t-cells |
| 09/20/2011 | CA2443403C 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
| 09/20/2011 | CA2440067C Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same |
| 09/20/2011 | CA2439415C Cathepsin cysteine protease inhibitors |
| 09/20/2011 | CA2426348C Retrovirus isolated from humans |
| 09/20/2011 | CA2426334C Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/20/2011 | CA2417904C Compounds acting as melanocortin receptor ligands |
| 09/20/2011 | CA2416519C Transportation of nucleic acid substances |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2374043C A somatotropin composition with improved syringeability |
| 09/20/2011 | CA2367373C Medicinal compositions |
| 09/20/2011 | CA2367149C Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 09/20/2011 | CA2356009C Vascular endothelial growth factor-x |
| 09/20/2011 | CA2354475C Blends of isoflavones and flavones |
| 09/20/2011 | CA2347170C Non-fermented osmotic laxative for treating and preventing colorectal cancers |
| 09/20/2011 | CA2259144C Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 09/20/2011 | CA2223573C Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |